Biogen, LendingClub, IBM, and More: Here’s What Analysts Had to Say About These Five Stocks

Page 1 of 2

Although the Federal Reserve has hiked rates again, the markets are little changed. The Dow Jones is down by just 8 points while the S&P and NASDAQ are close to flat. In this article, let’s find out what analysts had to say about Biogen Inc (NASDAQ:BIIB), Masimo Corporation (NASDAQ:MASI), LendingClub Corp (NYSE:LC), International Business Machines Corp. (NYSE:IBM), and Intevac, Inc. (NASDAQ:IVAC) and use the latest 13F data to determine hedge fund sentiment among the names.

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 39.7% gains over the past 12 months and outperformed the 24.1% gain enjoyed by the S&P 500 ETFs. Our enhanced small-cap hedge fund strategy returned more than 45% over the last 12 months and outperformed SPY by more than 30 percentage points over the last 4.5 years (see details here).

ibm, building, business, sign, wall, uk, laptop, tech fair, corporation, office automation, worldwide, international business, international fair, innovation, hardware, london,

JuliusKielaitis /

Biogen Inc (NASDAQ:BIIB) shares have sunk 5% after two investment banks, Morgan Stanley and Leerink, both downgraded the stock. Specifically, Morgan Stanley downgraded Biogen to ‘Equal Weight’ from ‘Overweight’ and trimmed its price target to $305 from $369 while Leerink lowered its rating to ‘Market Perform’ from ‘Outperform’ and cut its price target to $300 from $305. The latter downgraded due to the slower-than-expected sales pace of Spinraza, among other factors. 76 elite funds had a bullish position in Biogen Inc (NASDAQ:BIIB) at the end of the fourth quarter, down 5 funds from the previous quarter.

Follow Biogen Inc. (NASDAQ:BIIB)

Masimo Corporation (NASDAQ:MASI) is 4% in the red after William Quirk of Piper Jaffray downgraded the stock to ‘Neutral’ from ‘Overweight’. The analyst notes that Masimo shares have already rallied 146% since the announcement of the new management compensation package that incentivized a potential sale. Due to that rally, Quirk thinks there might be limited upside. He has a $80 price target. 24 top funds were long Masimo Corporation (NASDAQ:MASI) at the end of the fourth quarter, down 2 funds from the previous quarter.

Follow Masimo Corp (NASDAQ:MASI)

On the next page, we examine the analyst commentary surrounding LendingClub Corp, International Business Machines Corp, and Intevac Inc.

Page 1 of 2